المؤلفون: Leal T; Winship Cancer Institute at Emory University, Atlanta, GA 30322, USA. Electronic address: ticiana.a.leal@emory.edu., Langer C; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

المصدر: The Lancet. Oncology [Lancet Oncol] 2023 Dec; Vol. 24 (12), pp. e454.

نوع المنشور: Letter

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Lung Neoplasms*/therapy , Small Cell Lung Carcinoma*, Humans

المؤلفون: Leal T; Winship Cancer Institute at Emory University, Atlanta, GA, USA. Electronic address: ticiana.a.leal@emory.edu., Kotecha R; Miami Cancer Institute, Baptist Health South Florida, Miami, FL, USA., Ramlau R; Poznan University of Medical Sciences, Poznan, Poland., Zhang L; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center (SYSUCC), Guangzhou, China., Milanowski J; Medical University of Lublin, Lublin, Poland., Cobo M; Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Málaga, Spain., Roubec J; Nemocnice AGEL Ostrava-Vítkovice, Ostrava, Czech Republic., Petruzelka L; General University Hospital in Prague, Prague, Czech Republic., Havel L; Thomayer Hospital, Prague, Czech Republic., Kalmadi S; Ironwood Cancer & Research Centers, Chandler, AZ, USA., Ward J; Washington University School of Medicine, St Louis, MO, USA., Andric Z; University Clinical Hospital Centre Bezanijska Kosa, Belgrade, Serbia., Berghmans T; Jules Bordet Institute, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium., Gerber DE; Harold C Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA., Kloecker G; University of Louisville, Louisville, KY, USA., Panikkar R; Geisinger Cancer Institute, Danville, PA, USA., Aerts J; Department of Pulmonary Medicine, The Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands., Delmonte A; IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori (IRST), Meldola, Italy., Pless M; Kantonsspital Winterthur, Winterthur, Switzerland., Greil R; Salzburg Cancer Research Institute-Center for Clinical Cancer and Immunology Trials (SCRI-CCCIT), Salzburg, Austria; Paracelsus Medical University Salzburg, Salzburg, Austria; Cancer Cluster, Salzburg, Austria., Rolfo C; Center for Thoracic Oncology, Tisch Cancer Institute at Icahn School of Medicine, Mount Sinai, New York, NY, USA., Akerley W; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Eaton M; St Francis Hospital, Indianapolis, IN, USA., Iqbal M; College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada., Langer C; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

مؤلفون مشاركون: LUNAR Study Investigators

المصدر: The Lancet. Oncology [Lancet Oncol] 2023 Sep; Vol. 24 (9), pp. 1002-1017.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/therapy , Lung Neoplasms*/therapy, Humans ; Female ; Male ; Middle Aged ; Immune Checkpoint Inhibitors ; Nivolumab ; Docetaxel

المؤلفون: Kim KN; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA. Electronic address: Kristine.kim2@pennmedicine.upenn.edu., Heintz J; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Yegya-Raman N; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Cohen R; Division of Hematology Oncology, Department of Internal Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Kegelman T; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Cengel K; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Marmarelis M; Division of Hematology Oncology, Department of Internal Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Sun L; Division of Hematology Oncology, Department of Internal Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Langer C; Division of Hematology Oncology, Department of Internal Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Aggarwal C; Division of Hematology Oncology, Department of Internal Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Singh A; Division of Hematology Oncology, Department of Internal Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Singhal S; Division of Thoracic Surgery, Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Kucharczuk J; Division of Thoracic Surgery, Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Robinson K; Division of Hematology Oncology, Department of Internal Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Feigenberg S; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.

المصدر: Clinical lung cancer [Clin Lung Cancer] 2023 Mar; Vol. 24 (2), pp. e78-e86. Date of Electronic Publication: 2022 Dec 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/radiotherapy , Carcinoma, Non-Small-Cell Lung*/surgery , Lung Neoplasms*/radiotherapy , Lung Neoplasms*/surgery , Radiotherapy, Conformal* , Radiotherapy, Intensity-Modulated*/adverse effects , Radiotherapy, Intensity-Modulated*/methods, Humans ; Retrospective Studies ; Treatment Outcome ; Neoplasm Recurrence, Local/surgery ; Radiotherapy, Adjuvant/adverse effects

المؤلفون: Garassino MC; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, 20133, Italy., Paz-Ares L; Hospital Universitario 12 de Octubre, CiberOnc, Universidad Complutense & CNIO, Madrid, 28041, Spain., Hui R; Westmead Hospital & the University of Sydney, Sydney, NSW, 2145, Australia., Faivre-Finn C; The University of Manchester & The Christie NHS Foundation Trust, Manchester, M20 4BX, UK., Spira A; Virginia Cancer Specialists Research Institute, Fairfax, VA, & US Oncology Research, The Woodlands, TX 22031, USA., Planchard D; Institut Gustave Roussy, Department of Medical Oncology, Thoracic Group, Villejuif, 94805, France., Özgüroğlu M; Istanbul University - Cerrahpaşa, Cerrahpaşa School of Medicine, Istanbul, 34320, Turkey., Daniel D; Sarah Cannon Research Institute/Tennessee Oncology, Chattanooga, TN 37203, USA., Vicente D; Hospital Universitario Virgen Macarena, Seville, 41009, Spain., Murakami S; Kanagawa Cancer Center, Yokohama, 241-8515, Japan., Langer C; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA., Senan S; Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, 1081, The Netherlands., Spigel D; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN 3720231, USA., Rydén A; AstraZeneca, Gothenburg, 431 50, Sweden., Zhang Y; AstraZeneca, Gaithersburg, MD 20878, USA., O'Brien C; AstraZeneca, Cambridge, CB4 0WG, UK., Dennis PA; AstraZeneca, Gaithersburg, MD 20878, USA., Antonia SJ; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.

المصدر: Future oncology (London, England) [Future Oncol] 2021 Apr; Vol. 17 (10), pp. 1165-1184. Date of Electronic Publication: 2021 Feb 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*therapeutic use , Carcinoma, Non-Small-Cell Lung/*drug therapy , Carcinoma, Non-Small-Cell Lung/*pathology , Immune Checkpoint Inhibitors/*therapeutic use , Lung Neoplasms/*drug therapy , Lung Neoplasms/*pathology, Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal/adverse effects ; B7-H1 Antigen/antagonists & inhibitors ; B7-H1 Antigen/genetics ; Carcinoma, Non-Small-Cell Lung/etiology ; Carcinoma, Non-Small-Cell Lung/mortality ; Female ; Humans ; Immune Checkpoint Inhibitors/administration & dosage ; Immune Checkpoint Inhibitors/adverse effects ; Lung Neoplasms/etiology ; Lung Neoplasms/mortality ; Male ; Molecular Targeted Therapy ; Neoplasm Staging ; Patient Reported Outcome Measures ; Retrospective Studies ; Treatment Outcome

المؤلفون: Predina JD; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Division of Thoracic Surgery, Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Haas AR; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Division of Pulmonary, Allergy and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Martinez M; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Division of Pulmonary, Allergy and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., O'Brien S; Division of Pulmonary, Allergy and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Moon EK; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Division of Pulmonary, Allergy and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Woodruff P; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Division of Pulmonary, Allergy and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Stadanlick J; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Division of Thoracic Surgery, Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Corbett C; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Division of Thoracic Surgery, Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Frenzel-Sulyok L; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Division of Thoracic Surgery, Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Bryski MG; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Division of Thoracic Surgery, Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Eruslanov E; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Division of Thoracic Surgery, Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Deshpande C; Pulmonary and Mediastinal Pathology, Department of Clinical Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Langer C; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, MA, USA., Aguilar LK; Advantagene, Inc. d.b.a. Candel Therapeutics, Needham, MA, USA., Guzik BW; Advantagene, Inc. d.b.a. Candel Therapeutics, Needham, MA, USA., Manzanera AG; Advantagene, Inc. d.b.a. Candel Therapeutics, Needham, MA, USA., Aguilar-Cordova E; Advantagene, Inc. d.b.a. Candel Therapeutics, Needham, MA, USA., Singhal S; Division of Thoracic Surgery, Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Albelda SM; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Division of Pulmonary, Allergy and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: albelda@pennmedicine.upenn.edu.

المصدر: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2021 Feb 03; Vol. 29 (2), pp. 658-670. Date of Electronic Publication: 2020 Nov 05.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-0024 (Electronic) Linking ISSN: 15250016 NLM ISO Abbreviation: Mol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Genetic Therapy*/methods, Carcinoma, Non-Small-Cell Lung/*immunology , Carcinoma, Non-Small-Cell Lung/*therapy , Immunotherapy/*methods , Lung Neoplasms/*immunology , Lung Neoplasms/*therapy, Adenoviridae/genetics ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/metabolism ; Carcinoma, Non-Small-Cell Lung/pathology ; Cytotoxicity, Immunologic ; Genetic Vectors/administration & dosage ; Genetic Vectors/genetics ; Humans ; Lung Neoplasms/pathology ; Neoadjuvant Therapy ; Thymidine Kinase/genetics

المؤلفون: Faivre-Finn C; The University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK. Electronic address: corinne.finn@nhs.net., Spigel DR; Tennessee Oncology, Chattanooga, TN, USA; Sarah Cannon Research Institute, Nashville, TN, USA., Senan S; Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Langer C; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Perez BA; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Özgüroğlu M; Istanbul University - Cerrahpaşa, Cerrahpaşa School of Medicine, Istanbul, Turkey., Daniel D; Tennessee Oncology, Chattanooga, TN, USA; Sarah Cannon Research Institute, Nashville, TN, USA., Villegas A; Cancer Specialists of North Florida, Jacksonville, FL, USA., Vicente D; Hospital Universitario Virgen Macarena, Seville, Spain., Hui R; Westmead Hospital and the University of Sydney, Sydney, NSW, Australia., Murakami S; Kanagawa Cancer Center, Yokohama, Japan., Paz-Ares L; Hospital Universitario 12 de Octubre, Lung Cancer Unit CNIO-H12o, CiberOnc and Universidad Complutense, Madrid, Spain., Broadhurst H; Plus-Project Ltd, Alderley Park, UK., Wadsworth C; AstraZeneca, Alderley Park, UK., Dennis PA; AstraZeneca, Gaithersburg, MD, USA., Antonia SJ; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

المصدر: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2021 Jan; Vol. 151, pp. 30-38. Date of Electronic Publication: 2020 Nov 26.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal*/therapeutic use , Carcinoma, Non-Small-Cell Lung*/drug therapy , Lung Neoplasms*/drug therapy, Chemoradiotherapy ; Humans

المؤلفون: Paz-Ares L; Hospital Universitario 12 de Octubre, Lung Cancer Unit CNIO-H12o, CiberOnc and Universidad Complutense, Madrid, Spain. Electronic address: lpazaresr@seom.org., Spira A; Virginia Health Specialists, Fairfax, USA., Raben D; Department of Radiation Oncology, University of Colorado Denver, Aurora, USA., Planchard D; Gustave Roussy, Department of Medical Oncology, Thoracic Unit, Villejuif, France., Cho BC; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea., Özgüroğlu M; Istanbul University - Cerrahpaşa, Cerrahpaşa School of Medicine, Istanbul, Turkey., Daniel D; Tennessee Oncology, Chattanooga and Sarah Cannon Research Institute, Nashville, USA., Villegas A; Cancer Specialists of North Florida, Jacksonville, USA., Vicente D; Department of Clinical Oncology, H.U.V. Macarena, Seville, Spain., Hui R; Westmead Hospital and University of Sydney, Sydney, Australia., Murakami S; Kanagawa Cancer Center, Yokohama, Japan., Spigel D; Tennessee Oncology, Chattanooga and Sarah Cannon Research Institute, Nashville, USA., Senan S; Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Langer CJ; Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA., Perez BA; H. Lee Moffitt Cancer Center and Research Institute, Tampa, USA., Boothman AM; AstraZeneca, Cambridge, UK., Broadhurst H; Plus-Project Ltd, Alderley Park, UK., Wadsworth C; AstraZeneca, Alderley Park, UK., Dennis PA; AstraZeneca, Gaithersburg, USA., Antonia SJ; H. Lee Moffitt Cancer Center and Research Institute, Tampa, USA., Faivre-Finn C; The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK.

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2020 Jun; Vol. 31 (6), pp. 798-806. Date of Electronic Publication: 2020 Mar 21.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics, Antibodies, Monoclonal ; B7-H1 Antigen ; Humans

المؤلفون: Grewal AS; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Min EJ; Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania., Long Q; Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania., Grewal SK; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Jain V; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Levin WP; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Cengel KA; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Swisher-McClure S; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Aggarwal C; Medical Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Bauml JM; Medical Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Singh A; Medical Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Ciunci C; Medical Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Cohen RB; Medical Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Langer C; Medical Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Feigenberg SJ; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Berman AT; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: abigail.berman@pennmedicine.upenn.edu.

المصدر: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2020 Feb 01; Vol. 106 (2), pp. 358-368. Date of Electronic Publication: 2019 Oct 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE

مواضيع طبية MeSH: Proton Therapy*, Carcinoma, Non-Small-Cell Lung/*diagnostic imaging , Carcinoma, Non-Small-Cell Lung/*therapy , Chemoradiotherapy/*methods , Lung Neoplasms/*diagnostic imaging , Lung Neoplasms/*therapy, Adenocarcinoma/diagnostic imaging ; Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Adenocarcinoma/radiotherapy ; Adult ; Aged ; Aged, 80 and over ; Carcinoma, Non-Small-Cell Lung/mortality ; Carcinoma, Non-Small-Cell Lung/pathology ; Carcinoma, Squamous Cell/diagnostic imaging ; Carcinoma, Squamous Cell/mortality ; Carcinoma, Squamous Cell/pathology ; Carcinoma, Squamous Cell/radiotherapy ; Four-Dimensional Computed Tomography ; Humans ; Kaplan-Meier Estimate ; Lung Neoplasms/mortality ; Lung Neoplasms/pathology ; Lymph Nodes/diagnostic imaging ; Lymph Nodes/pathology ; Lymphatic Irradiation ; Middle Aged ; Progression-Free Survival ; Radiotherapy Dosage ; Remission Induction ; Retrospective Studies ; Time Factors ; Treatment Outcome ; Tumor Burden

المؤلفون: Hammer M; Department of Radiology, Brigham and Women's Hospital, Boston, MA; Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Bagley S; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Aggarwal C; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Bauml J; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Nachiappan AC; Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Simone CB 2nd; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD., Langer C; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Katz SI; Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA. Electronic address: sharyn.katz@uphs.upenn.edu.

المصدر: Current problems in diagnostic radiology [Curr Probl Diagn Radiol] 2019 Mar - Apr; Vol. 48 (2), pp. 142-147. Date of Electronic Publication: 2018 Jan 31.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Mosby Country of Publication: United States NLM ID: 7607123 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-6302 (Electronic) Linking ISSN: 03630188 NLM ISO Abbreviation: Curr Probl Diagn Radiol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized/*therapeutic use , Antineoplastic Agents, Immunological/*therapeutic use , Carcinoma, Non-Small-Cell Lung/*diagnostic imaging , Carcinoma, Non-Small-Cell Lung/*drug therapy , Lung Neoplasms/*diagnostic imaging , Lung Neoplasms/*drug therapy , Nivolumab/*therapeutic use , Pneumonia/*diagnostic imaging , Programmed Cell Death 1 Receptor/*antagonists & inhibitors, Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Humanized/adverse effects ; Antineoplastic Agents, Immunological/adverse effects ; Carcinoma, Non-Small-Cell Lung/immunology ; Female ; Humans ; Lung Neoplasms/immunology ; Male ; Middle Aged ; Nivolumab/adverse effects ; Pneumonia/chemically induced ; Pneumonia/immunology ; Retrospective Studies ; Tomography, X-Ray Computed ; Treatment Outcome

المؤلفون: Gridelli C; Division of Medical Oncology, S.G. Moscati Hospital, Avellino, Italy., de Castro Carpeno J; Division of Medical Oncology, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain., Dingemans AC; Department of Pulmonology, Maastricht University Medical Center, Maastricht, the Netherlands., Griesinger F; Department of Hematology and Oncology, University Department of Internal Medicine-Oncology, Pius-Hospital, University of Oldenburg, Oldenburg, Germany., Grossi F; Lung Cancer Unit, Ospedale Policlinico San Martino, Genova, Italy., Langer C; Thoracic Oncology Unit, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Ohe Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Syrigos K; Department of Medicine, National and Kapodistrian University, Athens, Greece., Thatcher N; Christie Hospital NHS Trust, Manchester, United Kingdom., Das-Gupta A; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Truman M; Roche Products Pty Ltd, Sydney, New South Wales, Australia.; Now with OzBiostat Pty Ltd, Manly, New South Wales, Australia., Donica M; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Smoljanovic V; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Bennouna J; Institut de Cancérologie de l'Ouest, Nantes, France.

المصدر: JAMA oncology [JAMA Oncol] 2018 Dec 01; Vol. 4 (12), pp. e183486. Date of Electronic Publication: 2018 Dec 13.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Standard of Care*, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Bevacizumab/*administration & dosage , Bevacizumab/*adverse effects , Carcinoma, Non-Small-Cell Lung/*drug therapy , Lung Neoplasms/*drug therapy, Adult ; Aged ; Aged, 80 and over ; Carcinoma, Non-Small-Cell Lung/mortality ; Carcinoma, Non-Small-Cell Lung/pathology ; Combined Modality Therapy/adverse effects ; Disease Progression ; Disease-Free Survival ; Female ; Humans ; Lung Neoplasms/mortality ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Survival Analysis ; Treatment Outcome